Actinogen Medical Ltd与FDA达成协议,就Xanamem阿尔茨海默病药物未来美国上市审批所需的制造、临床及非临床活动事宜举行C类会议

美股速递
Sep 15, 2025

Actinogen Medical Ltd与FDA在C类会议中就其阿尔茨海默病治疗药物Xanamem未来在美国市场获得批准所需的制造、临床和非临床活动达成了协议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10